Proteomic Characterization of AS1411 Reveals ATP6AP1 as a Mediator of Triple-Negative Breast Cancer Progression. [PDF]
Bae HS +6 more
europepmc +1 more source
Therapeutic Potential of Peptides in Cancer Treatment: Focus on Peptide and Aptamer-Decorated Exosomes. [PDF]
Gangadaran P +14 more
europepmc +1 more source
Research advances in aptamers in the diagnosis and treatment of breast cancer (Review). [PDF]
Chu L +6 more
europepmc +1 more source
Aptamers in Ocular Disease Therapy and Drug Delivery: Current Progress and Future Opportunities. [PDF]
Durán-Cristiano SC +2 more
europepmc +1 more source
COF@DNAzyme Empowering Endogenous Copper for One-Stitch Bioorthogonal Catalysis-Based Anticancer Therapy. [PDF]
Jiang M +9 more
europepmc +1 more source
Fulfilling multiple roles in PROTAC design: The emerging potential of oligonucleotides. [PDF]
Rodrigues DA +4 more
europepmc +1 more source
Advances in Aptamer Diagnostics Targeting Non-Small-Cell Lung Cancer: A Systematic Review. [PDF]
Agnello L +8 more
europepmc +1 more source
Quantitative oncogene-mapping within malignant tumors through Multi-parameter MRI based on RNA-triggered nanoprobes. [PDF]
Li W +8 more
europepmc +1 more source
Targeted Strategies for Treatment of Colorectal Cancer: Exploring the Use of Aptamers and Gold Nanoparticles. [PDF]
Oladunjoye BB +4 more
europepmc +1 more source
Mechanistic Studies of Anticancer Aptamer AS1411 Reveal a Novel Role for Nucleolin in Regulating Rac1 Activation [PDF]
AS1411 is a G‐rich quadruplex‐forming oligodeoxynucleotide that binds specifically to nucleolin, a protein found on the surface and in the cytoplasm of most malignant cells but absent from the surface/cytoplasm of most normal cells.
Matthew K Forsthoefel
exaly +4 more sources

